Ellipsys Medical
Ellipsys Medical, Inc.
Ellipsys Vascular Access System |
ellipsysmedical.com · San Clemente, CA
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$3.8M of $10.8M
Filed2026-09-08
Days since filing25
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-08-22
Investors
No investors named: Form D does not list them
This round was amended. Amendment filing
Officers on the filing
Names and roles as filed; addresses are never stored- FRANK HETTMANNExecutive Officer · Director
- ED CHANGDirector
- MARK RITCHARTDirector
- STEVE PARKERDirector
- JEFFREY HULLDirector
- BRIAN DRISCOLLDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged74.6% sold1.4 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedFlaggedD/A on 2026-09-29Amount offered unchanged or not stated
Open roles
On the employer's own careers page · checked 2026-09-210
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-02, against 71 in the 28 days before.